Cargando…
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures
BACKGROUND: Several autoimmune features occur during coronavirus disease 2019 (COVID‐19), with possible implications for disease course, immunity, and autoimmune pathology. In this study, we longitudinally screened for clinically relevant systemic autoantibodies to assess their prevalence, temporal...
Autores principales: | Taeschler, Patrick, Cervia, Carlo, Zurbuchen, Yves, Hasler, Sara, Pou, Christian, Tan, Ziyang, Adamo, Sarah, Raeber, Miro E., Bächli, Esther, Rudiger, Alain, Stüssi‐Helbling, Melina, Huber, Lars C., Brodin, Petter, Nilsson, Jakob, Probst‐Müller, Elsbeth, Boyman, Onur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111424/ https://www.ncbi.nlm.nih.gov/pubmed/35364615 http://dx.doi.org/10.1111/all.15302 |
Ejemplares similares
-
T‐cell recovery and evidence of persistent immune activation 12 months after severe COVID‐19
por: Taeschler, Patrick, et al.
Publicado: (2022) -
Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
por: Cervia, Carlo, et al.
Publicado: (2022) -
A distinct innate immune signature marks progression from mild to severe COVID-19
por: Chevrier, Stéphane, et al.
Publicado: (2020) -
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19
por: Cervia, Carlo, et al.
Publicado: (2021) -
Profound dysregulation of T cell homeostasis and function in patients with severe COVID‐19
por: Adamo, Sarah, et al.
Publicado: (2021)